These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33236337)

  • 21. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
    Peng CH; Jhang JF; Shie JH; Kuo HC
    Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Wang HJ; Yu WR; Ong HL; Kuo HC
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
    Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amniotic bladder therapy: six-month follow up treating interstitial cystitis/bladder pain syndrome.
    Considine J; O'Hollaren K; Radoiu C; Madan R; Liaw A; Dhar N
    Can J Urol; 2024 Jun; 31(3):11898-11903. PubMed ID: 38912944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
    Kuo HC
    Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
    Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
    Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis].
    Xin P; Zhang H; Jiang ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):865-870. PubMed ID: 37807741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index.
    Pires MV; de Lima CJ; Carvalho HC; Moreira LH; Fernandes AB
    Int Urogynecol J; 2023 Jul; 34(7):1437-1446. PubMed ID: 36242631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum A (AboBTXA) among women with refractory interstitial cystitis/bladder pain syndrome.
    Manning J; Dwyer P; Rosamilia A; Colyvas K; Murray C; Fitzgerald E
    Int Urogynecol J; 2014 May; 25(5):593-9. PubMed ID: 24276074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
    Yu WR; Jhang JF; Kuo HC
    Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified Botulinum Toxin Type A Injections Improve Symptoms Associated With Interstitial Cystitis/Bladder Pain Syndrome in Women: A Retrospective Cohort Study.
    Wang Y; Zheng J; Li Z; Jiang Y; Yu J; Li S; Chen X
    Urology; 2024 Jul; 189():27-33. PubMed ID: 38710455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A.
    Pinto R; Lopes T; Costa D; Barros S; Silva J; Silva C; Cruz C; Dinis P; Cruz F
    Urology; 2014 May; 83(5):1030-4. PubMed ID: 24767520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis.
    Giannantoni A; Gubbiotti M; Bini V
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.
    Yunfeng G; Fei L; Junbo L; Dingyuan Y; Chaoyou H
    Int Urol Nephrol; 2022 Mar; 54(3):479-491. PubMed ID: 35044552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis.
    Chen JL; Kuo HC
    Investig Clin Urol; 2020 Feb; 61(Suppl 1):S33-S42. PubMed ID: 32055752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.